Evidence map›Paper›PMID 39825728›Full record

ArticleJournal of neurochemistry2025

Sub-Microliter

Alireza Abaei, Dinesh K Deelchand, Jan Kassubek, Francescois Roselli, Volker Rasche

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alireza AbaeiCore Facility Small Animal MRI, Ulm University, Ulm, Germany.ORCID 0000-0003-2287-6495
Dinesh K DeelchandCenter for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-4266-4780
Jan KassubekDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0002-7106-9270
Francescois RoselliDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0001-9935-6899
Volker RascheCore Facility Small Animal MRI, Ulm University, Ulm, Germany.ORCID 0000-0001-8844-3583

Funding

TRD4 - Ultrahigh Field Engineering and SafetyP41EB027061 · NIBIB · UNIVERSITY OF MINNESOTA · PI Gregory John Metzger, KAMIL UGURBIL · 2019 to 2026
$11.7M
Institutional Center Cores for Advanced NeuroimagingP30NS076408 · NINDS · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2020
$4.2M
Deutsche Forschungsgemeinschaft (German Research Foundation) 447235146NIBIB NIH HHS P41 EB027061NIH HHS P30 NS076408NIH HHS P41 EB027061NINDS NIH HHS P30 NS076408
6 · The paper itself

Abstract

Proton magnetic resonance spectroscopy (MRS) offers a non-invasive, repeatable, and reproducible method for in vivo metabolite profiling of the brain and other tissues. However, metabolite fingerprinting by MRS requires high signal-to-noise ratios for accurate metabolite quantification, which has traditionally been limited to large volumes of interest, compromising spatial fidelity. In this study, we introduce a new optimized pipeline that combines LASER MRS acquisition at 11.7 T with a cryogenic coil and advanced offline pre- and post-processing. This approach achieves a signal-to-noise ratio sufficient to reliably quantify 19 distinct metabolites in a volume as small as 0.7 μL within the mouse brain. The resulting high spatial resolution and spectral quality enable the identification of distinct metabolite fingerprints in small, specific regions, as demonstrated by characteristic differences in N-acetylaspartate, glutamate, taurine, and myo-inositol between the motor and somatosensory cortices. We demonstrated a decline in taurine and glutamate in the primary motor cortex between 5 and 11 months of age, against the stability of other metabolites. Further exploitation to cortical layer-specific metabolite fingerprinting of layer I-III to layer VI-V in the primary motor cortex, with the latter showing reduced taurine and phosphoethanolamine levels, demonstrates the potential of this pipeline for detailed in vivo metabolite fingerprinting of cortical areas and subareas.

Indexed as

BrainProton Magnetic Resonance SpectroscopyAnimalsAspartic AcidMaleMiceMice, Inbred C57BLMotor CortexTaurineAspartic AcidN-acetylaspartateTaurinecortical areashigh spatial resolutionmagnetic resonance spectroscopymetabolite profile

Identifiers

PMID39825728
PMCPMC11742661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.